Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol TERT contributors: mct/ - updated : 11-09-2019
HGNC name telomerase reverse transcriptase
HGNC id 11730
ASSOCIATED DISORDERS
corresponding disease(s) DKC3
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral       gain of function
in cancer
tumoral     --over  
with BIRC5 in soft tissue sarcoma with very poor outlook
constitutional somatic mutation      
impair telomerase activity by haploinsufficiency and may be risk factors for marrow failure
constitutional     --over  
increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines
tumoral somatic mutation      
in 71p 100 of melanomas (pMID: 23348506)
tumoral germinal mutation      
mutations creating Ets/TCF binding motifs in the TERT promoter in familial melanoma
Susceptibility
  • susceptibility to idiopathic pulmonary fibrosis
  • to lung adenocarcinoma
  • to squamous cell carcinoma of the head and neck
  • to haematological malignancies, including myelodysplastic syndrome and acute myeloid leukaemia as well as chronic lymphocytic leukaemia
  • to age-related disease idiopathic pulmonary fibrosis with telomere shortening
  • to testicular germ cell tumor (TGCT)
  • to variation of telomere length, to Telomere length (TL) shortening
  • to uveal melanoma (UM)
  • Variant & Polymorphism SNP
  • significant association of an SNP in intron 2 of the TERT gene (rs2736100), which encodes a reverse transcriptase that is a component of a telomerase, to idiopathic pulmonary fibrosis
  • variants in TERT can impede telomere elongation causing stem cells to enter premature replicative senescence and/or apoptosis as telomeres become critically short
  • SNPs of TERT-rs2736098 (C > T) and CLPTM1L-rs401681(C > T), may be associated with a reduced risk of squamous cell carcinoma of the head and neck, particularly for their combined effect
  • rs2736100 associated with risk of lung adenocarcinoma
  • association between genetic marker rs2735940 and TGCT risk
  • variants associated with increased risk of haematological malignancies, including myelodysplastic syndrome and acute myeloid leukaemia as well as chronic lymphocytic leukaemia
  • two non-synonymous substitutions in the catalytic domain of the telomerase reverse transcriptase gene TERT: V791I and V867M increasing the risk of age-related disease idiopathic pulmonary fibrosis with telomere shortening
  • in UM rs452384 is a functional variant that mediates allele-specific binding of the NKX2.4 nuclear factor and the transcriptional activity of the region, including TERT and CLPTM1L
  • exposure to polycyclic aromatic hydrocarbons (PAHs) can accelerate the TL shortening and this effect can be modified by TERT-CLPTM1L variants
  • Candidate gene
    Marker
    Therapy target
  • TERT gene-based drug design may be useful in the treatment of leukemic myelopoiesis
  • ANIMAL & CELL MODELS
  • mouse lacking telomerase activity display decrease proliferation in testis and increased apoptosis